DSRU says more research needed to understand immunocompromised patients’ responses to COVID-19 vaccines
Studies showed immunosuppression appeared to weaken immune responses to COVID-19 vaccines
Read More
Tag: immunosuppression
Conditional approval for Hansa’s kidney transplant drug
Idefirix is an immunosuppressant that reduces the level of donor specific antibodies, thus enabling transplantation
Read More
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
